Endometriosis: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• VEGF 0
• CTNNB1 0
• PPAR 0
• PI3K 0
• TP53 0
• AKT 0
• NLRP3 0
• TNF 0
• IL-6 0
• MMP-9 0
• NRF2 0
• AMPK 0
• ERK 0
• HIF-1 0
• JAK 0
• mTOR 0
• PTEN 0
• SIRT1 0
• TLR4 0
• HSP90 0
• MAPK 0
• STAT3 0
• BRCA1 0
• COX-2 0
• CXCR4 0
• EGFR 0
• ESR1 0
• HMGB1 0
• IL-1 0
• PD-1 0
• PKM2 0
• STING 0
• TREM2 0
• YAP 0
• BAP1 0
• BCL-2 0
• BDNF 0
• BRCA2 0
• CCR5 0
• CGRP 1
• CSF1R 0
• FAK 0
• FGFR 0
• FOXP3 0
• G6PD 0
• GPX4 0
• JNK 0
• KRAS 1
• LAG-3 0
• MDM2 0
• MYC 0
• PARP 0
• PD-L1 0
• PDGFR 0
• PRMT5 0
• SGLT2 0
• TIGIT 0
• VHL 0

1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NINDS · RF1

  Neuroendocrine mechanisms of female chronic overlapping pain conditions (COPC)

  University of Arizona· Tucson, United States· US$3,462,365 awarded in fiscal year 2026· until Aug 2030

• NIH NICHD · R01

  Decoding Dysmenorrhea: Longitudinal Modeling of Pelvic Pain Phenotypes in Adolescents and Young Adults

  Mclean Hospital· Belmont, United States· US$695,377 awarded in fiscal year 2026· until May 2031

• NIH NIAID · R01

  Mycoplasma genitalium in Women: Natural History, Clinical Sequelae, and Host-Microbiome-Mediated Clearance

  University of Maryland Baltimore· Baltimore, United States· US$804,984 awarded in fiscal year 2026· until Aug 2031

• NIH NEI · R01

  Beyond the Eye: Nociplastic Pain as a Predictor of Treatment Response in Chronic Ocular Surface Pain

  University of Michigan at Ann Arbor· Ann Arbor, United States· US$690,677 awarded in fiscal year 2026· until May 2031

• NIH NICHD · R01

  A Randomized Trial of Vitamin D Supplementation to Reduce Fibroid Growth

  Boston University Medical Campus· Boston, United States· US$754,653 awarded in fiscal year 2026· until Mar 2031

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Tracking the Intestinal Permeation and Circulation Effects of Environmental MicroPlastics (TRACE-MP)

  Queen Mary University of London· London, United Kingdom· EU contribution €292,073· until Jan 2029· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Uro-Lieve: Slow-Release Capsaicin Hydrogel for Disease-Modifying Therapy of Painful Bladder Syndrome

  University of Galway· Galway, Ireland· EU contribution €150,000· until Nov 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Simultaneous Yield of Non-invasive uterine Contractions via Wearable Observation and Real-time Monitoring A wearable platform for dynamic uterine motion capture. (SyncWorm)

  Gottfried Wilhelm Leibniz Universitaet Hannover· Hannover, Germany· EU contribution €150,000· until Nov 2027

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE

  Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility (TULIP)

  Karolinska Institutet· Stockholm, Sweden· EU contribution €1,803,600· until Dec 2029· 6 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Investigating how somatic mutation induced changes in the eutopic endometrial microenvironment cause endometriosis (MERMAID)

  Stichting Radboud Universitair Medisch Centrum· Nijmegen, Netherlands· EU contribution €232,916· until Dec 2027

10 of 148 running projects, newest first. Listed amounts together: US$90.0m + €27.6m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 21
• Organoids 13
• Mendelian Randomization Analysis 29
• CRISPR-Cas Systems 1
• Gene Expression Profiling 44
• Sequence Analysis, RNA 6
• Exome Sequencing 2
• Proteomics 12
• Metabolomics 7
• Mass Spectrometry 2
• Flow Cytometry 7
• Immunohistochemistry 18
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 53
• Machine Learning 31
• Deep Learning 4
• Cohort Studies 48
• Genome-Wide Association Study 34

• Birthweight trends for babies born using Assisted Reproductive Treatments between 1991 and 2018: a national cohort study.

  Hum Reprod, Nov 2026

• Correlation between endometriosis and chronic endometritis: A retrospective cohort study.

  Medicine (Baltimore), Oct 2026

• Endometrial preparation for embryo transfer: reproductive outcomes of modified natural cycle versus hormone replacement therapy.

  Rev Bras Ginecol Obstet, Oct 2026

• Use of Ibuprofen Before and in Early Pregnancy Among Women With and Without Chronic Medical Diseases. A Cross-Sectional Study.

  Pharmacoepidemiol Drug Saf, Oct 2026

• Sexual intercourse frequency and fecundability in the Norwegian mother, father and child cohort study.

  PLoS One, Sept 2026

• Association between endometriosis and cardiovascular disease: a population-based cohort study.

  J Glob Health, Sept 2026

• Ultrasound Sliding Sign Assessed by Transvaginal or Transrectal Route for Predicting Complete Pouch of Douglas Obliteration in Patients with Ovarian Endometriomas: An Exploratory Retrospective Study.

  Medicina (Kaunas), Sept 2026

• Incidence and factors associated with premature ovarian insufficiency: a population-based cohort study.

  Hum Reprod, Sept 2026

• Endometriosis subtypes and risk of type 2 diabetes: the Advancing Research on Cardiovascular Health and Endometriosis Study (ARCHES) retrospective cohort study.

  Diabetologia, Aug 2026

• Autoimmune hypothyroidism and endometriosis: evidence from bidirectional Mendelian randomization and an independent clinical cohort analysis.

  Front Endocrinol (Lausanne), Aug 2026

See which targets of this disease your abstract mentions, and go to the people working on them.